
Enoxaviz 40 Injection
Marketer
Vistica Life Sciences
Salt Composition
Enoxaparin (40mg)
Overview Enoxaviz 40 Injection
Enoxaparin 40mg Injection is an anticoagulant medication preventing and treating dangerous blood clots. It inhibits clot growth and formation. It's also used to prevent venous thromboembolism, including deep vein thrombosis and pulmonary embolism. Administration is subcutaneous, performed by a healthcare professional; intramuscular injection is contraindicated. Dosage and treatment duration depend on individual factors like medical history, response to treatment, underlying condition, age, and weight. Continued use is crucial, even without noticeable symptoms, to mitigate future complications; discontinuation increases clot risk. Avoid activities increasing bleeding or injury risk during treatment. Common side effects include injection site discomfort, bleeding, headache, thrombocytosis, respiratory issues, swelling, anemia, pyrexia, diarrhea, and elevated liver enzymes. Severe headache may indicate intracranial hemorrhage; severe abdominal pain may suggest gastrointestinal bleeding. Bleeding, potentially subtle, can be serious; monitor for symptoms and report concerns promptly. Inform your doctor of pre-existing conditions such as hypertension, diabetes, or recent cerebrovascular accident before commencing treatment. Contraindicated in active bleeding. Consult your physician about potential drug interactions; concurrent medications require careful consideration. Low body weight elevates bleeding risk, further amplified by alcohol consumption, potentially increasing the risk of gastrointestinal hemorrhage.
Uses of Enoxaviz 40 Injection
Preventing and managing blood clot formation
Major Benefits of Enoxaviz 40 Injection:
Administering this medication will be handled by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Enoxaviz 40 Injection:
- Bleeding
- Headache
- Low blood platelets
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Fever
- Injection site pain
- Breathing problems
- Edema (swelling)
- Diarrhea
How to use Enoxaviz 40 Injection:
Administering this medication requires a healthcare professional; self-medication is strictly prohibited.
How Enoxaviz 40 Injection works:
Enoxaparin 40 mg Injection is a blood thinner. Its mechanism of action involves the neutralization of specific clotting factors in the blood, thus inhibiting clot development and subsequent vessel obstructions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Enoxaviz 40 Injection may be unsafe; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The use of Enoxaviz 40 Injection during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for fetal development; clinical data from human studies, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, the use of Enoxaviz 40 Injection appears to be safe. Preliminary human studies indicate minimal risk to the infant. The drug's transfer into breast milk is negligible, resulting in insignificant quantities reaching the baby, posing no anticipated harm.
DrivingSAFE
Driving ability is typically unaffected by Enoxaviz 40 Injection.
KidneyCAUTION
Patients with kidney impairment should use Enoxaviz 40 Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Enoxaviz 40 Injection's application in individuals with hepatic impairment. Physician consultation is recommended. Nevertheless, its administration to patients with pre-existing liver conditions should be approached with prudence.
What if you forget to take Enoxaviz 40 Injection :
Omit a dose of Enoxaviz 40 Injection? Seek your physician's advice immediately.
Facts to Know About Enoxaviz 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Low-molecular-weight heparin (LMWH) |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Low-molecular-weight heparin (LMWH) |
